Bayer Other Current Assets from 2010 to 2026

BAYA Stock  EUR 10.70  0.20  1.83%   
Bayer Aktiengesellscha's Other Current Assets are decreasing over the last several years with slightly volatile swings. Other Current Assets are estimated to finish at about 900.7 M this year. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2010-12-31
Previous Quarter
468.9 M
Current Value
900.7 M
Quarterly Volatility
547 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bayer Aktiengesellscha financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bayer Aktiengesellscha's main balance sheet or income statement drivers, such as Tax Provision of 181.3 M, Interest Income of 361.3 M or Discontinued Operations of 6.1 B, as well as many indicators such as . Bayer financial statements analysis is a perfect complement when working with Bayer Aktiengesellscha Valuation or Volatility modules.
  
This module can also supplement various Bayer Aktiengesellscha Technical models . Check out the analysis of Bayer Aktiengesellscha Correlation against competitors.
The Other Current Assets trend for Bayer Aktiengesellschaft offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bayer Aktiengesellscha is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Bayer Aktiengesellscha's Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of Bayer Aktiengesellschaft over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. Bayer Aktiengesellscha's Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bayer Aktiengesellscha's overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Slightly volatile
   Other Current Assets   
       Timeline  

Bayer Other Current Assets Regression Statistics

Arithmetic Mean969,328,571
Geometric Mean869,082,457
Coefficient Of Variation56.43
Mean Deviation330,475,630
Median1,031,000,000
Standard Deviation547,003,486
Sample Variance299212.8T
Range2.3B
R-Value(0.36)
Mean Square Error277083T
R-Squared0.13
Significance0.15
Slope(39,331,408)
Total Sum of Squares4787405T

Bayer Other Current Assets History

2026900.7 M
2025468.9 M
2022521 M
2021545 M
2020674 M
20191.5 B
2018794 M

About Bayer Aktiengesellscha Financial Statements

Bayer Aktiengesellscha stakeholders use historical fundamental indicators, such as Bayer Aktiengesellscha's Other Current Assets, to determine how well the company is positioned to perform in the future. Although Bayer Aktiengesellscha investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bayer Aktiengesellscha's assets and liabilities are reflected in the revenues and expenses on Bayer Aktiengesellscha's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bayer Aktiengesellschaft. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Assets468.9 M900.7 M

Currently Active Assets on Macroaxis

Other Information on Investing in Bayer Stock

Bayer Aktiengesellscha financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer Aktiengesellscha security.